/term/bs-payables-and-accrued-expenses/FRA:BS50 Inotiv (FRA:BS50) Accounts Payable & Accrued Expense for Fi
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (FRA:BS50) » Definitions » Accounts Payable & Accrued Expense for Financial Companies

Inotiv (FRA:BS50) Accounts Payable & Accrued Expense for Financial Companies


View and export this data going back to 1997. Start your Free Trial

What is Inotiv Accounts Payable & Accrued Expense for Financial Companies?

Accounts Payable & Accrued Expense for Financial Companies only applies to insurance companies.

Inotiv (FRA:BS50) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Inotiv Inc (FRA:BS50) » Definitions » Accounts Payable & Accrued Expense for Financial Companies
Comparable Companies
ENZ VNRX BIOQ STIM OCX PSNL PRE XGN SLDX BIAF TMO DHR A IDXX IQV XSWX:LONN MTD ICLR WAT ILMN
Traded in Other Exchanges
NOTV:USA BS50:Germany
Address
2701 Kent Avenue, West Lafayette, IN, USA, 47906
Website
https://www.inotivco.com
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.